Controversies in Vascular Composite Allotransplantation (VCA) Friday, October 9 Fri, Oct 9
This course will cover the latest trends and developments in vascularized composit allotransplantation, including face, hand, abdominal wall, and genitourinary. Specific focus will be on immunological concepts and cost-benefit analysis of the unique allotransplants.
At the end of this activity participants will be able to:
- Discuss the newest cases and latest innovations in VCA as of 2020;
- Describe techniques for face, hand, abdominal wall, and genitourinary VCA;
- Identify the risks and benefits of different immunosuppressive protocols;
- Discuss the financial risks and benefits of starting a VCA program.
Educational Grant Support Provided By: LEADERS: Allergan Aesthetics, an AbbVie Company; Galderma Laboratories, L.P.; Galatea Surgical, Inc.; INNOVATORS: Mentor Worldwide, LLC; SUPPORTERS: Johnson & Johnson Medical Devices Companies
In-Kind Support Provided By: Galatea Surgical, Inc.; Johnson & Johnson Medical Devices Companies
Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.
Designation: The ASPS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.